Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis
Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis
Active, not recruiting · NCT04217356 · Registry updated 2026-07-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, bone marrow cancer, bone marrow disorder, bone marrow neoplasm, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm, primary myelofibrosis | Active, not recruiting | Not stated | 2026-07-06 | NCT04217356 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Health Network, Toronto | 417 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cross Cancer Institute | Edmonton | Canada | 1 |
| Nova Scotia Health Authority | Halifax | Canada | 3 |
| Princess Margaret Cancer Centre | Toronto | Canada | 11 |
| St. Paul's Hospital | Vancouver | Canada | 2 |
| Tom Baker Cancer Centre | Calgary | Canada | 4 |